case-study-page
knowledge

Hillrom and Welch Allyn—Improving Chronic Care Management Together

You're on the front line of population health.

In a complex healthcare system, community health centers represent the first line of defense against the health issues patients face today. Effectively managing chronic conditions and identifying risk factors early can help you achieve better outcomes at a lower cost while improving both the clinician and patient experience.

At Hillrom, we give you smart tools to help you identify, diagnose and manage the prevalent health issues you see every day.

Ready to Speak with a Representative?

click here

 

"" play_circle_outline

BIGGER, BRIGHTER VIEWS

Examining the structure of the eye and ear is a fleeting yet critical part of the physical exam. That’s why we’ve listened to countless providers and redesigned our otoscopes and ophthalmoscopes for enhanced exams. Let us change your view.

LEARN MORE

SIMPLIFY, SECURE AND CONNECT CARDIAC CARE

The Welch Allyn ELI 280 electrocardiograph provides comprehensive functionality in a portable touchscreen device. The easy-to-use device is designed to meet the demands of high-volume ECG environments

EXPERIENCE THE ELI 280
IN YOUR OWN SPACE

A child sits on a mother’s lap while the clinician sits across from them completing a vision screening with the Welch Allyn® Spot® Vision Screener.

SIGHT-SAVING PEDIATRIC SCREENING

Vision disability is the single most prevalent disabling condition among children.1 The AAP recommends instrument-based vision screening as early as 12 months of age, if available.2 Yet, 70% of pediatricians are not doing automated vision screening.3

The Welch Allyn Spot Vision Screener can quickly and easily detect vision disorders in children to help improve sight and prevent blindness.

LEARN MORE

PRECISE HYPERTENSION MANAGEMENT

Get a handle on hypertension with better blood pressure management with Welch Allyn smart solutions.

Better understand how to diagnose hypertension to help meet the challenge for your patients, your practice and your community.

EXPLORE OUR SOLUTIONS

A clinician fastens a blood pressure cuff to a patient’s arm with the Welch Allyn® Spot® Vital Signs device in the background.

CLOSING THE DIABETIC RETINAL EXAM CARE GAP

Up to 80% of individuals with diabetes will eventually develop some stage of diabetic retinopathy.4 With early detection, up to 95% of vision loss from diabetic retinopathy—the leading cause of blindness for working-age adults5—is preventable.6 The Welch Allyn RetinaVue care delivery model makes diabetic retinal exams simple and affordable for community health centers.

REQUEST A VIRTUAL DEMO

""

Improving Chronic Care Management?

Ask how an investment in our latest diagnostic solutions can help your team detect and manage prevalent, chronic health issues.

Unlock up to $15,000 in rebates when you purchase any combination of four qualifying devices.

$300 Rebate

Green Series 777 Integrated Wall System

Qualifying Models:
777-PM3WAS-US, 777-PM3WAX-US, 777-PM3WCX-US, 777-PM3WXS-US, 777-PM3WXX-US

$300 Rebate

Welch Allyn Universal Charger and Desk Set

Qualifying Model:
71-PM3LDE-US

$300 Rebate

Diagnostic Cardiology Suite with Optional Spirometry

Qualifying Models:
CC-RXX-WAXX, CC-RXX-WADX, CC-RXX-AAXX, CC-RXX-AADX, DCSS-CXX, DCSS-NXX

$300 Rebate

Welch Allyn ELI 280

Qualifying Models:
ELI280-AAA-AAFBD
ELI280-CAA-AAFBD
ELI280-CAA-AAFBT
ELI280-AAA-AAFBT
BUR280-C1X, BUR280-81X
BUR280-W1X

$400 Rebate

Welch Allyn Spot Vision Screener

Qualifying Model:
VS100S-B

$800 Rebate

Welch Allyn RetinaVue 700 Imager*

Qualifying Model: RV700-B
*RetinaVue Software subscription required as part of the RetinaVue care delivery model.

$200 Rebate

Welch Allyn Connex Spot Monitor

Qualifying Models:
73 Series, 74 Series
75 Series

$300 Rebate

Welch Allyn Connex Integrated Wall System

Qualifying Models:
84MTVE2-US, 84MTVX2-US
84NTVE2-US, 84NTVX2-US
85MTVE3-US, 85MTVX3-US
85NTVE3-US, 85NTVX3-US
44WT-B, 44XT-B
Offer available on eligible purchases made April 15 - September 30, 2022, by Federally Qualified Community Health Centers only. To be eligible for offer, customer must purchase at least 4 Qualifying Devices identified in this document on one purchase order and provide proof of purchase as indicated on the redemption form found at www.hillrom.com/improvechroniccare22. Limit one rebate submission per customer for up to a maximum total rebate amount of $15,000. The maximum rebate amount applies per customer, regardless of the number of customer locations (i.e., a customer is subject to the maximum rebate amount of $15,000 regardless of whether the customer has 1 location or 100 locations). All information must be submitted via the online redemption process by November 15, 2022. Customers must submit a completed W-9. Promotion valid in U.S. only. Distributor stocking orders do not qualify. Please allow 12 weeks for receipt of rebate check. Promotion cannot be combined with any other promotion, offer, coupon, enhanced discount or special pricing arrangement; some exclusions may apply. Connex, Diagnostic Cardiology Suite, ELI 280, Green Series, RetinaVue, Spot Vision Screener, Welch Allyn are trademarks of Baxter International, Inc. or its subsidiaries.

ALL RIGHTS RESERVED

  

Let’s Connect

Fill out the form below to connect with a representative and learn more about how Hillrom can help you maximize care with the right solutions for your patients.

""
Download our guide, Improving Chronic Care Management
""
Download our latest promotion exclusively for Community Health Centers
References
  1. Centers for Disease Control and Prevention: Fast Facts of Common Eye Disorders. https://www.cdc.gov/visionhealth/basics/ced/fastfacts.htm
  2. Wyckoff, Alyson Sulaski, and Associate Editor. “New Reports Shine Light on Vision Screening for Primary Care Offices,” December 7, 2015. https://publications.aap.org/aapnews/news/12308/New-reports-shine-light-on-vision-screening-for.
  3. Welch Allyn Market Research 2016
  4. Duration of diabetes is a major risk factor associated with the development of diabetic retinopathy. After five years, approximately 25% of type 1 patients will have retinopathy, increasing to 80% after 15 years. For type 2 patients, the risk of developing retinopathy is 84% and 53% after 19 years for those taking or not taking insulin, respectively. Diabetic Retinopathy Preferred Practice Pattern® from the American Academy of Ophthalmology, http://dx.doi.org/10.1016/j.ophtha.2019.09.025, ISSN 0161-6420/19. Accessed July 29, 2020.
  5. Centers for Disease Control and Prevention. Vision Health Initiative (VHI). https://www.cdc.gov/visionhealth/basics/ced/ Published September 29, 2015.
  6. National Eye Institute. People With Diabetes Can Prevent Vision Loss. https://www.nei.nih.gov/sites/default/files/2019-06/diabetes-prevent-vision-loss.pdf